There are currently 29 active clinical trials seeking participants for Psychosis research studies. The states with the highest number of trials for Autism participants are California, New York, Massachusetts and Ontario.
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
Recruiting
Single-blind, randomized controlled trial of normobaric oxygen therapy among individuals with first-episode psychosis: Effects on symptomatology and cognition.
Gender:
All
Ages:
Between 15 years and 35 years
Trial Updated:
07/31/2023
Locations: Harding Hospital, Columbus, Ohio
Conditions: Psychosis, Schizophrenia, First-episode Psychosis
EPI-MINN: Targeting Cognition and Motivation
Recruiting
The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. Participants who are enrolled in a chart review study of measurement-based care will be recruited to participate in this study. In the measurement-based care study, participants are enrolled in coordinated specialty care programs fo... Read More
Gender:
All
Ages:
Between 15 years and 40 years
Trial Updated:
04/22/2024
Locations: Human Development Center, Duluth, Minnesota +2 locations
Conditions: Psychosis
Neural Basis of Social Cognition Deficits
Recruiting
Difficulties in reciprocal social interaction are hallmark features of several neuropsychiatric disorders, most notably autism spectrum disorder (ASD) and schizophrenia spectrum disorder (SSD). While recent studies have demonstrated substantial overlap in genetic etiology between ASD and SSD, little is known about common versus unique neural mechanisms that may underlie these downstream social deficits that cross diagnostic boundaries. Thus, a comprehensive imaging study examining social deficit... Read More
Gender:
All
Ages:
Between 12 years and 18 years
Trial Updated:
04/03/2024
Locations: Loma Linda U, Loma Linda, California
Conditions: Autism Spectrum Disorder, Psychosis, Social Communication
Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
Recruiting
This is a randomized, controlled clinical trial to assess the effects of the ketogenic diet in combination with treatment as usual on brain energy metabolism and psychiatric symptoms in individuals with first episode bipolar disorder and schizoaffective disorder.
Gender:
All
Ages:
Between 18 years and 45 years
Trial Updated:
04/02/2024
Locations: McLean Hospital, Belmont, Massachusetts
Conditions: Bipolar I Disorder, Psychosis, Schizoaffective Disorder
Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk
Recruiting
This 10 week intervention, Specific Cognitive Remediation with Surround (or SCORES), is designed to target processing speed, a cognitive domain related directly to social functioning, which in turn, represents a vulnerability factor for psychosis. This remotely-delivered intervention combining targeted cognitive training exercises and group support was developed to directly impact processing speed, and at the same time, boost motivation and engagement in adolescents at risk for schizophrenia and... Read More
Gender:
All
Ages:
Between 14 years and 20 years
Trial Updated:
03/15/2024
Locations: Northwell Health- The Zucker Hillside Hospital, Glen Oaks, New York
Conditions: Psychosis, Prodromal Schizophrenia, Prodromal Symptoms
State Representation in Early Psychosis
Recruiting
The purpose of this study is to examine state representation in individuals aged 15-45 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigators will complete some observational tests as well as a cognitive training clinical trial.
Gender:
All
Ages:
Between 15 years and 45 years
Trial Updated:
02/14/2024
Locations: University of Minnesota, Minneapolis, Minnesota
Conditions: Psychosis, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Schizoaffective Disorder
State Representation in Early Psychosis - Project 4
Recruiting
The purpose of this study is to examine state representation in individuals aged 15-45 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigators will complete a clinical trial examining two paradigms of cognitive training.
Gender:
All
Ages:
Between 15 years and 45 years
Trial Updated:
02/08/2024
Locations: University of Minnesota, Minneapolis, Minnesota
Conditions: Psychosis, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Schizoaffective Disorder
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Recruiting
This proposal will examine the effects of estradiol administration on perimenopausal-onset (PO) anhedonia and psychosis symptoms as well as on brain function using simultaneous positron emission tomography and functional magnetic resonance imaging (PET-MR).
Gender:
Female
Ages:
Between 45 years and 55 years
Trial Updated:
01/24/2024
Locations: University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Conditions: Depression, Psychosis, Anhedonia
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
Recruiting
This clinical trial is a single center, single dose study of the acute effects of intranasal insulin on energy metabolism and cognitive function in patients with schizophrenia, schizoaffective and bipolar disorders, compared and healthy controls.
Gender:
All
Ages:
Between 18 years and 40 years
Trial Updated:
12/15/2023
Locations: McLean Hospital, Belmont, Massachusetts
Conditions: Psychosis, Schizophrenia, Schizo Affective Disorder, Bipolar I Disorder
Improving Hallucinations by Targeting the rSTS With tES
Recruiting
Hallucinations are a core diagnostic feature of psychotic disorders. They involve different sensory modalities, including auditory, visual, olfactory, tactile, and gustatory hallucinations, among others. Hallucinations occur in multiple different neurological and psychiatric illnesses and can be refractory to existing treatments. Auditory hallucinations and visual hallucinations are found across diagnostic categories of psychotic disorders (schizophrenia, schizoaffective, bipolar disorder). Desp... Read More
Gender:
All
Ages:
Between 18 years and 50 years
Trial Updated:
12/11/2023
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Conditions: Hallucinations, Auditory, Psychosis
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
Recruiting
The purpose of this study is to better understand mental illness and will test the hypotheses that while viewing affective stimuli, patient groups will show increased blood oxygenation level dependent (BOLD) signal by fMRI after lorazepam. This study will enroll participants between the ages of 16 and 60, who have a psychotic illness (such as psychosis which includes conditions like schizophrenia, schizoaffective disorder, and mood disorders). The study will also enroll eligible participants wi... Read More
Gender:
All
Ages:
Between 16 years and 60 years
Trial Updated:
11/30/2023
Locations: University of Michigan, Ann Arbor, Michigan
Conditions: Schizophrenia, Bipolar Disorder, Healthy, Psychosis, Schizophreniform Disorders, Schizo Affective Disorder, Major Depression With Psychotic Features
Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study
Recruiting
Psychosis is a heterogeneous disorder and present treatment only works for a limited number of patients. In order to identify new therapeutic targets, this study will longitudinally characterize the underlying pathologies in those with poor treatment response using complimentary brain imaging modalities.
Gender:
All
Ages:
Between 17 years and 35 years
Trial Updated:
11/27/2023
Locations: Sparks Center, Birmingham, Alabama
Conditions: Psychosis